• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

17p13杂合性缺失,可能涉及ACADVL和ALOX15B,在肾上腺皮质肿瘤发病机制中的作用。

Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.

作者信息

Soon Patsy S H, Libe Rossella, Benn Diana E, Gill Anthony, Shaw Janet, Sywak Mark S, Groussin Lionel, Bertagna Xavier, Gicquel Christine, Bertherat Jerome, McDonald Kerrie L, Sidhu Stan B, Robinson Bruce G

机构信息

Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia.

出版信息

Ann Surg. 2008 Jan;247(1):157-64. doi: 10.1097/SLA.0b013e318153ff55.

DOI:10.1097/SLA.0b013e318153ff55
PMID:18156936
Abstract

OBJECTIVE

To determine the minimal common region of loss on 17p13 in a cohort of adrenocortical carcinomas (ACCs) (defined by a Weiss score > or =3) and adrenocortical adenomas (ACAs) (defined by a Weiss score <3) and subsequently to assess 3 genes in this region that could be involved in adrenocortical tumorigenesis.

SUMMARY BACKGROUND DATA

Loss of heterozygosity (LOH) of 17p13 has been demonstrated to occur more frequently in ACCs compared with ACAs.

METHODS

Using 12 microsatellite markers across 17p13, LOH analysis was performed on 37 paired blood and adrenocortical tumor samples (23 ACC and 14 ACA samples) to determine the minimal common region of loss for ACCs and ACAs. From this minimal region of loss, 3 genes were selected for quantitative real time reverse transcription polymerase chain reaction analysis on 20 ACCs and 30 ACAs.

RESULTS

LOH at 17p13 was found in 74% of ACCs compared with 14% of ACAs. There was a 10.4-Mb common minimal region of loss in ACCs whereas no minimal region of loss in ACAs could be demonstrated. Expression of Acyl coenzyme-A dehydrogenase very long chain (ACADVL) and Arachidonate 15-lipoxygenase second type (ALOX15B) was significantly down-regulated in ACCs compared with ACAs whereas there was no difference in expression of Potassium channel tetramerization domain containing 11 (KCTD11) in ACCs and ACAs.

CONCLUSIONS

We demonstrated a minimal common region of loss of 10.4-Mb on 17p13 in ACCs and within this region, we found that ACADVL and ALOX15B expression are good discriminators between ACCs and ACAs.

摘要

目的

确定一组肾上腺皮质癌(ACC,定义为Weiss评分≥3)和肾上腺皮质腺瘤(ACA,定义为Weiss评分<3)中17p13区域的最小共同缺失区域,随后评估该区域中可能参与肾上腺皮质肿瘤发生的3个基因。

总结背景数据

与ACA相比,17p13杂合性缺失(LOH)在ACC中更频繁发生。

方法

使用跨越17p13的12个微卫星标记,对37对血液和肾上腺皮质肿瘤样本(23个ACC样本和14个ACA样本)进行LOH分析,以确定ACC和ACA的最小共同缺失区域。从这个最小缺失区域中,选择3个基因对20个ACC和30个ACA进行定量实时逆转录聚合酶链反应分析。

结果

74%的ACC中发现17p13存在LOH,而ACA中这一比例为14%。ACC中有一个10.4Mb的共同最小缺失区域,而ACA中未发现最小缺失区域。与ACA相比,ACC中酰基辅酶A脱氢酶超长链(ACADVL)和花生四烯酸15-脂氧合酶2型(ALOX15B)的表达显著下调,而ACC和ACA中含钾通道四聚化结构域11(KCTD11)的表达没有差异。

结论

我们证明了ACC中17p13存在一个10.4Mb的最小共同缺失区域,在该区域内,我们发现ACADVL和ALOX15B的表达是区分ACC和ACA的良好指标。

相似文献

1
Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.17p13杂合性缺失,可能涉及ACADVL和ALOX15B,在肾上腺皮质肿瘤发病机制中的作用。
Ann Surg. 2008 Jan;247(1):157-64. doi: 10.1097/SLA.0b013e318153ff55.
2
Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.肾上腺皮质肿瘤的基因芯片表达和免疫组化分析表明,胰岛素样生长因子2(IGF2)和Ki-67有助于鉴别癌与腺瘤。
Endocr Relat Cancer. 2009 Jun;16(2):573-83. doi: 10.1677/ERC-08-0237. Epub 2009 Feb 13.
3
Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.在伴有常见的17号染色体短臂13区杂合性缺失的肾上腺皮质癌中,体细胞TP53突变相对少见。
Clin Cancer Res. 2007 Feb 1;13(3):844-50. doi: 10.1158/1078-0432.CCR-06-2085.
4
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.散发性肾上腺皮质肿瘤大样本队列中的分子标志物与长期复发情况
Cancer Res. 2001 Sep 15;61(18):6762-7.
5
Molecular markers and the pathogenesis of adrenocortical cancer.分子标志物与肾上腺皮质癌的发病机制
Oncologist. 2008 May;13(5):548-61. doi: 10.1634/theoncologist.2007-0243.
6
The glucocorticoid receptor is overexpressed in malignant adrenocortical tumors.糖皮质激素受体在恶性肾上腺皮质肿瘤中过表达。
J Clin Endocrinol Metab. 2009 Nov;94(11):4591-9. doi: 10.1210/jc.2009-0546. Epub 2009 Oct 9.
7
Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.孕酮和雌二醇受体在正常肾上腺皮质、肾上腺皮质肿瘤及原发性色素沉着性结节性肾上腺皮质疾病中的表达
Endocr Relat Cancer. 2008 Jun;15(2):465-74. doi: 10.1677/ERC-07-0081.
8
High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.甲状腺癌中17p13的高分辨率杂合性缺失图谱:嗜酸性细胞癌表现出一个小的411千碱基的等位基因不平衡共同区域,可能包含一个新的肿瘤抑制基因。
J Clin Endocrinol Metab. 2002 Oct;87(10):4715-21. doi: 10.1210/jc.2002-020708.
9
Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.人类肾上腺皮质肿瘤的整合分子生物信息学研究:微小RNA、组织特异性靶标预测及通路分析
Endocr Relat Cancer. 2009 Sep;16(3):895-906. doi: 10.1677/ERC-09-0096. Epub 2009 Jun 22.
10
[Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].肝细胞癌17号染色体p13.3区域杂合性缺失分析及缺失区域基因组重叠群构建
Zhonghua Zhong Liu Za Zhi. 2000 Sep;22(5):377-80.

引用本文的文献

1
Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation.基于网络药理学和实验评估的淫羊藿素对子宫内膜癌的作用机制
Front Oncol. 2023 Jul 19;13:1205604. doi: 10.3389/fonc.2023.1205604. eCollection 2023.
2
A mitochondria-related signature for predicting immune microenvironment and therapeutic response in osteosarcoma.一种用于预测骨肉瘤免疫微环境和治疗反应的线粒体相关特征。
Front Oncol. 2022 Dec 1;12:1085065. doi: 10.3389/fonc.2022.1085065. eCollection 2022.
3
Arachidonate 15-lipoxygenase type B: Regulation, function, and its role in pathophysiology.
B型花生四烯酸15-脂氧合酶:调控、功能及其在病理生理学中的作用。
Front Pharmacol. 2022 Nov 9;13:1042420. doi: 10.3389/fphar.2022.1042420. eCollection 2022.
4
Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence.基于人工智能建立的用于鉴别诊断肾上腺皮质癌和腺瘤的组织微小RNA组合
Cancers (Basel). 2022 Feb 11;14(4):895. doi: 10.3390/cancers14040895.
5
The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review.微小RNA在肾上腺皮质癌中的诊断、预后及治疗作用:一项系统综述
Biomedicines. 2021 Oct 20;9(11):1501. doi: 10.3390/biomedicines9111501.
6
Key MicroRNA's and Their Targetome in Adrenocortical Cancer.肾上腺皮质癌中的关键微小RNA及其靶标组
Cancers (Basel). 2020 Aug 6;12(8):2198. doi: 10.3390/cancers12082198.
7
Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.支架蛋白富含脯氨酸、谷氨酸和亮氨酸蛋白1(PELP1)在肾上腺皮质癌细胞生长调节中的作用。
Cells. 2017 Nov 7;6(4):42. doi: 10.3390/cells6040042.
8
Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression.TP53基因缺失的高级别浆液性卵巢癌进展中的肿瘤内异质性
BMC Cancer. 2015 Nov 30;15:940. doi: 10.1186/s12885-015-1952-z.
9
The role of lipoxygenases in pathophysiology; new insights and future perspectives.脂氧合酶在病理生理学中的作用;新见解与未来展望。
Redox Biol. 2015 Dec;6:297-310. doi: 10.1016/j.redox.2015.08.006. Epub 2015 Aug 7.
10
Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature.肾上腺皮质癌的诊断和预后特征:单机构病例系列及文献综述
World J Surg Oncol. 2015 Mar 24;13:117. doi: 10.1186/s12957-015-0527-4.